Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?
NCT04468802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2020-07-14
Summary
Mortality rates caused by SARS CoV-2 differ between countries and this difference might be explained by several reasons. Childhood vaccination rate is thought to be one of them. Therefore present study aimed to examine the possible relationship between DTaP (diphtheria, tetanus, pertussis) and measles vaccination rates of Organization for Economic Co-operation and Development (OECD) countries and case fatality rate (CFR) caused by SARS CoV-2.
Conditions
- Covid19
- Measles Vaccine
- Mortality
Interventions
- OTHER
-
Case fatality rate
Mortality rate caused by SARS CoV-2
Sponsors & Collaborators
-
Kanuni Sultan Suleyman Training and Research Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-02-01
- Primary Completion
- 2020-06-30
- Completion
- 2020-07-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience
NCT05614791 ·Status: COMPLETED
-
Measles Vaccine in HCW
NCT04357028 ·Status: SUSPENDED ·Phase: PHASE3
-
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610 ·Status: UNKNOWN
-
The Interaction Between Measles and DTP Vaccination
NCT02710045 ·Status: COMPLETED ·Phase: NA
-
Measles Vaccination at Health System Contacts
NCT04220671 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Prophylactic Antibiotics in Measles
NCT00168532 ·Status: COMPLETED ·Phase: PHASE3
-
Measles and BCG Vaccines for Mother and Child
NCT04899765 ·Status: RECRUITING ·Phase: PHASE4
-
Trial of Additional Measles Vaccine to Reduce Child Mortality
NCT01644721 ·Status: COMPLETED ·Phase: PHASE4
-
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
NCT02943681 ·Status: COMPLETED ·Phase: NA
-
Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children
NCT03460002 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.
NCT01668745 ·Status: COMPLETED ·Phase: PHASE4
-
Early Two-dose Measles Vaccination Trial
NCT00168558 ·Status: COMPLETED ·Phase: PHASE4
-
Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)
NCT05154097 ·Status: UNKNOWN
-
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
NCT05758532 ·Status: RECRUITING ·Phase: PHASE4
-
Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings
NCT06667206 ·Status: RECRUITING ·Phase: PHASE2
-
Long-term Follow-up of Measles Antibodies
NCT00168571 ·Status: COMPLETED ·Phase: PHASE4
-
Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients
NCT01770119 ·Status: RECRUITING ·Phase: PHASE4
-
Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed
NCT05592756 ·Status: COMPLETED
-
Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors
NCT01602094 ·Status: UNKNOWN
-
Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
NCT05425823 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
NCT00891007 ·Status: COMPLETED ·Phase: PHASE2
-
Measles, Mumps, and Rubella (MMR) Immunity in College Students
NCT00962819 ·Status: COMPLETED
-
BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa
NCT07005726 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?
NCT04658680 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Can Earlier BCG Vaccination Reduce Early Infant Mortality? A Randomised Trial
NCT02504203 ·Status: TERMINATED ·Phase: PHASE4